Joshua Jennings
Stock Analyst at TD Cowen
(3.17)
# 1,160
Out of 4,969 analysts
70
Total ratings
44.62%
Success rate
3.36%
Average return
Main Sectors:
Stocks Rated by Joshua Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUMA Humacyte | Maintains: Buy | $5 → $3.5 | $1.46 | +139.73% | 3 | Aug 12, 2025 | |
| SENS Senseonics Holdings | Initiates: Buy | $1.25 | $0.45 | +176.55% | 1 | Jul 15, 2025 | |
| AVR Anteris Technologies Global | Initiates: Buy | $15 | $4.14 | +262.32% | 1 | Jan 7, 2025 | |
| PODD Insulet | Maintains: Buy | $264 → $324 | $343.53 | -5.69% | 1 | Jan 3, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $100 → $110 | $107.53 | +2.30% | 7 | Dec 12, 2024 | |
| CBLL CeriBell | Maintains: Buy | $31 → $36 | $11.61 | +210.08% | 2 | Dec 9, 2024 | |
| TMDX TransMedics Group | Maintains: Buy | $175 → $120 | $106.94 | +12.21% | 9 | Nov 18, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $50 | $2.12 | +2,258.49% | 1 | Oct 2, 2024 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $75 → $99 | $37.84 | +161.63% | 3 | Sep 16, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Hold | $143 → $119 | $105.04 | +13.29% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $60 | $33.55 | +78.84% | 2 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $80 | $81.34 | -1.65% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $45 | $13.73 | +227.75% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $100 → $70 | $81.22 | -13.81% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $185 | $178.00 | +3.93% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 | $23.54 | +69.92% | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $365 → $400 | $388.56 | +2.94% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $60 | $38.61 | +55.40% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $34 | $12.35 | +175.30% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $18 | $4.32 | +316.67% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $114 → $125 | $78.92 | +58.39% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $25 | $16.55 | +51.06% | 1 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $130 | $132.18 | -1.65% | 9 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $5 | $2.71 | +84.50% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $117 | $92.25 | +26.83% | 3 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $450 | $5.84 | +7,605.48% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $12 | $15.90 | -24.53% | 1 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $306 → $275 | $189.61 | +45.03% | 1 | Feb 7, 2020 |
Humacyte
Aug 12, 2025
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.46
Upside: +139.73%
Senseonics Holdings
Jul 15, 2025
Initiates: Buy
Price Target: $1.25
Current: $0.45
Upside: +176.55%
Anteris Technologies Global
Jan 7, 2025
Initiates: Buy
Price Target: $15
Current: $4.14
Upside: +262.32%
Insulet
Jan 3, 2025
Maintains: Buy
Price Target: $264 → $324
Current: $343.53
Upside: -5.69%
Boston Scientific
Dec 12, 2024
Maintains: Buy
Price Target: $100 → $110
Current: $107.53
Upside: +2.30%
CeriBell
Dec 9, 2024
Maintains: Buy
Price Target: $31 → $36
Current: $11.61
Upside: +210.08%
TransMedics Group
Nov 18, 2024
Maintains: Buy
Price Target: $175 → $120
Current: $106.94
Upside: +12.21%
Allurion Technologies
Oct 2, 2024
Initiates: Buy
Price Target: $50
Current: $2.12
Upside: +2,258.49%
PROCEPT BioRobotics
Sep 16, 2024
Maintains: Buy
Price Target: $75 → $99
Current: $37.84
Upside: +161.63%
Zimmer Biomet Holdings
Sep 6, 2024
Maintains: Hold
Price Target: $143 → $119
Current: $105.04
Upside: +13.29%
Aug 27, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $33.55
Upside: +78.84%
Aug 13, 2024
Maintains: Hold
Price Target: $83 → $80
Current: $81.34
Upside: -1.65%
Aug 8, 2024
Maintains: Buy
Price Target: $135 → $45
Current: $13.73
Upside: +227.75%
Jul 25, 2024
Downgrades: Hold
Price Target: $100 → $70
Current: $81.22
Upside: -13.81%
Jul 18, 2024
Maintains: Buy
Price Target: $195 → $185
Current: $178.00
Upside: +3.93%
May 10, 2024
Downgrades: Hold
Price Target: $40
Current: $23.54
Upside: +69.92%
Apr 11, 2024
Maintains: Buy
Price Target: $365 → $400
Current: $388.56
Upside: +2.94%
Mar 12, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $38.61
Upside: +55.40%
Aug 4, 2023
Maintains: Outperform
Price Target: $52 → $34
Current: $12.35
Upside: +175.30%
May 11, 2023
Maintains: Outperform
Price Target: $14 → $18
Current: $4.32
Upside: +316.67%
Feb 10, 2023
Maintains: Outperform
Price Target: $114 → $125
Current: $78.92
Upside: +58.39%
Dec 30, 2022
Maintains: Outperform
Price Target: $6 → $25
Current: $16.55
Upside: +51.06%
Dec 13, 2022
Maintains: Outperform
Price Target: $130
Current: $132.18
Upside: -1.65%
Nov 11, 2022
Maintains: Outperform
Price Target: $7 → $5
Current: $2.71
Upside: +84.50%
May 27, 2022
Maintains: Outperform
Price Target: $125 → $117
Current: $92.25
Upside: +26.83%
Dec 7, 2021
Initiates: Outperform
Price Target: $450
Current: $5.84
Upside: +7,605.48%
Sep 3, 2020
Initiates: Outperform
Price Target: $12
Current: $15.90
Upside: -24.53%
Feb 7, 2020
Downgrades: Market Perform
Price Target: $306 → $275
Current: $189.61
Upside: +45.03%